Results 181 to 190 of about 22,412 (196)

Heparin-Induced Thrombocytopenia

Australian and New Zealand Journal of Medicine, 1988
Abstract:Thrombocytopenia is a common adverse effect of heparin therapy. Two types of heparinlinduced thrombocytopenia (HIT) are observed clinically ‐ an early onset mild thrombocytopenia (Type I) in which the patients remain asymptomatic and a delayed onset severe thrombocytopenia (Type II).
openaire   +5 more sources

Heparin-Induced Thrombocytopenia

Surgical Clinics of North America, 2012
This article deals with heparin-induced thrombocytopenia. It discusses the pathophysiology of the disease, as well as the diagnostic challenges and therapeutic management. The incidence of the disease and screening recommendations are reviewed. The article also emphasizes the importance of correct diagnosis and treatment options.
Stephen, Lanzarotti, John A, Weigelt
openaire   +2 more sources

Heparin induced thrombocytopenia

BMJ, 2015
This clinical review has been developed for The BMJ in collaboration with BMJ Best Practice, based on a regularly updated web/mobile topic that supports evidence based decision making at the point of care. To view the complete and current version, please refer to the heparin induced thrombocytopenia (http://bestpractice.bmj.com/best-practice/monograph ...
openaire   +2 more sources

Heparin-Induced Thrombocytopenia

JAMA: The Journal of the American Medical Association, 1979
Heparin, a drug responsible for a majority of drug deaths in patients who are reasonably healthy,1still eludes precise definition as to its structural composition.2Derived from mast cells of bovine lung and porcine gut, heparin preparations may vary in purity and antigenic effects.
openaire   +2 more sources

Heparin-Induced Immune Thrombocytopenia

New England Journal of Medicine, 1976
We studied five patients in whom severe thrombocytopenia developed during intermittent intravenous heparin treatment of arterial and venous thrombosis. Platelet aggregation was demonstrated when heparin (0.5 U per milliliter) was incubated with the patients' citrated platelet-rich plasma or with normal platelet-rich plasma in the presence of the ...
R B, Babcock, C W, Dumper, W B, Scharfman   +2 more
openaire   +2 more sources

Heparin-induced thrombocytopenia

Clinical Toxicology, 2014
Abstract A summary of heparin-induced thrombocytopenia (HIT) is presented. HIT is an adverse drug reaction characterized by thrombocytopenia and a high risk for venous or arterial thrombosis. The frequency of HIT ranges from 1 to 5% of patients receiving heparin with exact frequencies ranging between specific agents. Interestingly, this immune-mediated
openaire   +2 more sources

Heparin-Induced Thrombotic Thrombocytopenia

Chest, 1981
Following subcutaneous therapy with heparin, the patient developed signs and symptoms of vascular occlusion in both legs. This was accompanied by thrombocytopenia and platelet aggregation when the patient's platelets were incubated with heparin. The clinical features and implications of this syndrome are discussed.
G, Hollander, M, Bashevkin, H, Feldman, E, Lichstein   +3 more
openaire   +2 more sources

Heparin-Induced Thrombotic Thrombocytopenia

Annals of Pharmacotherapy, 1994
OBJECTIVE: To report a case of heparin-induced thrombotic thrombocytopenia (HITTS) and discuss the incidence, possible mechanisms, complications, and treatment for this syndrome. DATA SOURCES: Case reports and review articles identified by MEDLINE from 1980 through 1991. Older articles located by manual searches.
D E, Phillips, D K, Payne, G M, Mills
openaire   +2 more sources

Heparin-Induced Thrombocytopenia

Kardiologiia
The extensive use of therapeutic doses of heparin to prevent thrombosis in critically ill patients with COVID-19 during the pandemic has led to an increased incidence of bleeding and heparin-induced thrombocytopenia (HIT). In addition, the introduction of the AstraZeneca and Johnson&Johnson vaccines against COVID-19 into clinical practice was ...
openaire   +2 more sources

Heparin-induced thrombocytopenia

Current Treatment Options in Cardiovascular Medicine, 2001
Treatment with heparin is associated with two types of thrombocytopenia. The most worrisome of these is the immune-mediated heparin-induced thrombocytopenia (HIT type II). Suspicion of HIT type II mandates immediate cessation of heparin administration and consideration of an alternative anticoagulation therapy.
openaire   +2 more sources